Osaic Holdings
SLN

Osaic Holdings’s Silence Therapeutics SLN Stock Holding History

Osaic Holdings’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$18 – 8036
2025
Q4 		$18 Sell
3
-62,168
-100% -$398K ﹤0.01% 7744
2025
Q3 		$299K Sell
62,171
-7,210
-10% -$40K ﹤0.01% 3875
2025
Q2 		$402K Sell
69,381
-2,116
-3% -$9.07K ﹤0.01% 3338
2025
Q1 		$201K Buy
71,497
+30,630
+75% +$150K ﹤0.01% 3619
2024
Q4 		$281K Buy
40,867
+27,708
+211% +$358K ﹤0.01% 3287
2024
Q3 		$239K Buy
13,159
+318
+2% +$5.92K ﹤0.01% 3510
2024
Q2 		$244K Buy
12,841
+1,919
+18% +$40.8K ﹤0.01% 3382
2024
Q1 		$236K Buy
+10,922
New +$237K ﹤0.01% 3547
2023
Q3 		– Sell
-5
Closed -$27 – 7520
2023
Q2 		$27 Buy
+5
New +$30 ﹤0.01% 7360

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Osaic Holdings's SLN Position: Q1 2026 in Review

Osaic Holdings sold out of Silence Therapeutics (SLN) in Q1 2026, closing a stake of 3 shares — an estimated $18 sold.

Osaic Holdings first reported a position in SLN in Q2 2023 and held it in 9 quarters. The position peaked at $402K in Q2 2025. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Osaic Holdings reported no remaining Silence Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 3 Silence Therapeutics shares in Q1 2026, an estimated $18.
  • Osaic Holdings first reported a position in Silence Therapeutics in Q2 2023 and held it in 9 quarters.
  • Osaic Holdings's Silence Therapeutics position peaked at $402K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.